Provision Language
<p><span style=”font–weight: 400;”>2. The release set forth in <a href=”https://ghiaa.org/provision_document/bmgf–curevac–gsk–letter–agreement–for–alignment–on–global–access–commitments/” target=”_blank” rel=”noopener“>Section 1a> above shall remain in effect with respect to a CLA Product for as long as a vaccine or medicine of that nature is in development or being commercialized under the CLA. For clarity, the release in Section 1 above shall terminate as to any vaccine or medicine for which GSK has terminated the development or commercialisation in accordance with the CLA.span>p>
